Modulations of ferroptosis in lung cancer therapy

References

• Dixon SJ, Lemberg KM, Lamprecht MR, et al., Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• d’Amato TA, Landreneau RJ, Ricketts W, et al. Chemotherapy resistance and oncogene expression in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007;133(2):352–363.
   PubMed Web of Science ®Google Scholar
• Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69(1):69–85.
   PubMedGoogle Scholar
• Nakamura T, Naguro I, Ichijo H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim Biophys Acta Gen Subj. 2019;1863(9):1398–1409.
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59(2):298–308.
   PubMed Web of Science ®Google Scholar
• Tang M, Chen Z, Wu D, et al. Ferritinophagy/ferroptosis: iron-related newcomers in human diseases. J Cell Physiol. 2018;233:9179–9190.
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26(9):1021–1032.
   PubMed Web of Science ®Google Scholar
• Lai CS, Piette LH. Spin-trapping studies of hydroxyl radical production involved in lipid peroxidation. Arch Biochem Biophys. 1978;190(1):27–38.
   PubMed Web of Science ®Google Scholar
• Bannai S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem. 1986;261(5):2256–2263.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zheng Y, Wang C, et al. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis. 2018;9(7):753.
   PubMed Web of Science ®Google Scholar
• Lin X, Ping J, Wen Y, et al. The mechanism of ferroptosis and applications in tumor treatment. Front Pharmacol. 2020;11:1061.
   PubMed Web of Science ®Google Scholar
• Lv H, Zhen C, Liu J, et al. Unraveling the potential role of glutathione in multiple forms of cell death in cancer therapy. Oxid Med Cell Longev. 2019;2019:3150145.
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohé R, Maiorino M. Glutathione peroxidases. Biochim Biophys Acta. 2013;1830(5):3289–3303.
   PubMed Web of Science ®Google Scholar
• Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688–692.
   PubMed Web of Science ®Google Scholar
• Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693–698.
   PubMed Web of Science ®Google Scholar
• Wilson DF. Oxidative phosphorylation: regulation and role in cellular and tissue metabolism. J Physiol. 2017;595(23):7023–7038.
   PubMed Web of Science ®Google Scholar
• Galadari S, Rahman A, Pallichankandy S, et al. Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med. 2017;104:144–164.
   PubMed Web of Science ®Google Scholar
• Su L-J, Zhang J-H, Gomez H, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019;2019:5080843.
   PubMed Web of Science ®Google Scholar
• Frank CE. Hydrocarbon autoxidation. Chem Rev. 1950;46(1):155–169.
   PubMed Web of Science ®Google Scholar
• Kuhn H, Banthiya S, van Leyen K. Mammalian lipoxygenases and their biological relevance. Biochim Biophys Acta BBA - Mol Cell Biol Lipids. 2015;1851:308–330.
   PubMed Web of Science ®Google Scholar
• Golej DL, Askari B, Kramer F, et al. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells. J Lipid Res. 2011;52(4):782–793.
   PubMed Web of Science ®Google Scholar
• Borst JW, Visser NV, Kouptsova O, et al. Oxidation of unsaturated phospholipids in membrane bilayer mixtures is accompanied by membrane fluidity changes. Biochim Biophys Acta. 2000;1487(1):61–73.
   PubMed Web of Science ®Google Scholar
• Agmon E, Solon J, Bassereau P, et al. Modeling the effects of lipid peroxidation during ferroptosis on membrane properties. Sci Rep. 2018;8(1):5155.
   PubMedGoogle Scholar
• Jiang L, Kon N, Li T, et al., Ferroptosis as a p53-mediated activity during tumour suppression. Nat. 2015;520(7545): 57–62.
   Google Scholar
• Hu W, Zhang C, Wu R, et al. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A. 2010;107(16):7455–7460.
   PubMed Web of Science ®Google Scholar
• Ou Y, Wang S-J, Li D, et al. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A. 2016;113(44):E6806–E6812.
   PubMed Web of Science ®Google Scholar
• Loboda A, Damulewicz M, Pyza E, et al., Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221–3247
   PubMed Web of Science ®Google Scholar
• Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173–184.
   PubMed Web of Science ®Google Scholar
• Chang L-C, Chiang S-K, Chen S-E, et al. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 2018;416:124–137.
   PubMed Web of Science ®Google Scholar
• Kwon M-Y, Park E, Lee S-J, et al. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 2015;6(27):24393–24403.
   PubMedGoogle Scholar
• Xu W, Deng H, Hu S, et al. Role of Ferroptosis in Lung Diseases. J Inflamm Res. 2021;14:2079–2090.
   PubMed Web of Science ®Google Scholar
• Alam NA, Olpin S, Rowan A, et al. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn JMD. 2005;7(4):437–443.
   PubMed Web of Science ®Google Scholar
• Yuan H, Li X, Zhang X, et al. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. Biochem Biophys Res Commun. 2016;478(2):838–844.
   PubMed Web of Science ®Google Scholar
• Yagoda N, Von Rechenberg M, Zaganjor E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447(7146):864–868.
   PubMed Web of Science ®Google Scholar
• Li J, Cao F, Yin H, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104–107.
   PubMed Web of Science ®Google Scholar
• Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(1):110.
   PubMed Web of Science ®Google Scholar
• Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015;265(1):130–142.
   PubMed Web of Science ®Google Scholar
• Kang R, Tang D. Autophagy and ferroptosis - What’s the connection? Curr Pathobiol Rep. 2017;5(2):153–159.
   PubMedGoogle Scholar
• Tasdemir E, Chiara Maiuri M, Morselli E, et al. A dual role of p53 in the control of autophagy. Autophagy. 2008;4(6):810–814.
   PubMed Web of Science ®Google Scholar
• Desideri E, Filomeni G, Ciriolo MR. Glutathione participates in the modulation of starvation-induced autophagy in carcinoma cells. Autophagy. 2012;8(12):1769–1781.
   PubMed Web of Science ®Google Scholar
• Garg AD, Dudek AM, Ferreira GB, et al. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy. 2013;9(9):1292–1307.
   PubMed Web of Science ®Google Scholar
• Torti SV, Torti FM. Iron and cancer: 2020 Vision. Cancer Res. 2020;80(24):5435–5448.
   PubMed Web of Science ®Google Scholar
• Basuli D, Tesfay L, Deng Z, et al. Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene. 2017;36(29):4089–4099.
   PubMed Web of Science ®Google Scholar
• Kuang Y, Wang Q. Iron and lung cancer. Cancer Lett. 2019;464:56–61.
   PubMed Web of Science ®Google Scholar
• Wu J, Ma L, Wang J, et al. Mechanism of ferroptosis and its research progress in lung cancer. Zhongguo Fei Ai Za Zhi Chin J Lung Cancer. 2020;23:811–817.
   PubMedGoogle Scholar
• Zhou J, Wang X, Li Z, et al. Construction and analysis of a novel ferroptosis related gene signature predicting prognosis in lung adenocarcinoma. FEBS Open Bio. 2021;11(11):3005–3018.
   PubMedGoogle Scholar
• Li F, Ge D, Sun S. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma. BMC Pulm Med. 2021;21(1):229.
   PubMed Web of Science ®Google Scholar
• Han K, Wang J, Qian K, et al. Construction of a prognostic model for non-small-cell lung cancer based on ferroptosis-related genes. Biosci Rep. 2021;41(5):BSR20210527.
   PubMed Web of Science ®Google Scholar
• Zhu G, Huang H, Xu S, et al. Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma. Thorac Cancer. 2021;12(12):1890–1899.
   PubMed Web of Science ®Google Scholar
• Yao J, Chen X, Liu X, et al. Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma. Cancer Cell Int. 2021;21(1):340.
   PubMed Web of Science ®Google Scholar
• Mao C, Wang X, Liu Y, et al. A G3BP1-Interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Res. 2018;78(13):3484–3496.
   PubMed Web of Science ®Google Scholar
• Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369–379.
   PubMed Web of Science ®Google Scholar
• Huang C, Yang M, Deng J, et al., Upregulation and activation of p53 by erastin‑induced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells. Oncol Rep. 2018;40(4): 2363–2370
   PubMed Web of Science ®Google Scholar
• Liang Z, Zhao W, Li X, et al. Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells. Biochem Biophys Res Commun. 2021;569:79–85.
   PubMed Web of Science ®Google Scholar
• Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15(3):234–245.
   PubMedGoogle Scholar
• Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell. 2014;156(1–2):317–331.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sui S, Wang L, et al. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin. J Cell Physiol. 2020;235(4):3425–3437.
   PubMed Web of Science ®Google Scholar
• Guo J, Xu B, Han Q, et al., Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat. 2018;50(2): 445–460
   PubMed Web of Science ®Google Scholar
• Ni J, Chen K, Zhang J, et al. Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells. Biochem Biophys Res Commun. 2021;567:154–160.
   PubMed Web of Science ®Google Scholar
• Villalpando-Rodriguez GE, Blankstein AR, Konzelman C, et al. Lysosomal destabilizing drug siramesine and the dual tyrosine kinase inhibitor lapatinib induce a synergistic ferroptosis through reduced heme oxygenase-1 (HO-1) levels. Oxid Med Cell Longev. 2019;2019:9561281.
   PubMed Web of Science ®Google Scholar
• Zhang T, Sun B, Zhong C, et al. Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma. Transl Lung Cancer Res. 2021;10(4):1857–1872.
   PubMed Web of Science ®Google Scholar
• Li Y, Yan H, Xu X, et al., Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway. Oncol Lett. 2020;19(1): 323–333
   PubMed Web of Science ®Google Scholar
• Yuan B, Liao F, Shi -Z-Z, et al. Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2/SLC7A11 Axis. Oncol Targets Ther. 2020;13:10829–10840.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yi H, Yao H, et al. Artemisinin derivatives inhibit non-small cell lung cancer cells through induction of ros-dependent Apoptosis/Ferroptosis. J Cancer. 2021;12:4075–4085.
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhang J, Yan M, et al. Orlistat induces ferroptosis-like cell death of lung cancer cells. Front Med. 2021;15(6):922–932.
   PubMed Web of Science ®Google Scholar
• Meng M, Huang M, and Liu C, et al. Local anesthetic levobupivacaine induces ferroptosis and inhibits progression by up-regulating p53 in non-small cell lung cancer. Aging (Albany NY). 2021;13. doi:https://doi.org/10.18632/aging.203138.
   Google Scholar
• Freire Boullosa L, Van Loenhout J, Flieswasser T, et al. Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer. Redox Biol. 2021;42:101949.
   PubMed Web of Science ®Google Scholar
• Gai C, Yu M, Li Z, et al. Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer. J Cell Physiol. 2020;235(4):3329–3339.
   PubMed Web of Science ®Google Scholar
• Guan J, Lo M, Dockery P, et al. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine. Cancer Chemother Pharmacol. 2009;64(3):463–472.
   PubMed Web of Science ®Google Scholar
• Ji X, Qian J, Rahman SMJ, et al. xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene. 2018;37(36):5007–5019.
   PubMed Web of Science ®Google Scholar
• Chen P, Wu Q, Feng J, et al. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis. Signal Transduct Target Ther. 2020;5(1):51.
   PubMed Web of Science ®Google Scholar
• Tang X, Ding H, Liang M, et al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac Cancer. 2021;12(8):1219–1230.
   PubMed Web of Science ®Google Scholar
• Tsai Y, Xia C, Sun Z. The inhibitory effect of 6-Gingerol on ubiquitin-specific peptidase 14 enhances autophagy-dependent ferroptosis and anti-tumor in vivo and in vitro. Front Pharmacol. 2020;11:598555.
   PubMed Web of Science ®Google Scholar
• Wu C-Y, Yang Y-H, Lin Y-S, et al. Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells. Biomed Pharmacother Biomedecine Pharmacother. 2021;139:111585.
   PubMed Web of Science ®Google Scholar
• Wu W, Geng Z, Bai H, et al. Ammonium ferric citrate induced ferroptosis in non-small-cell lung carcinoma through the inhibition of GPX4-GSS/GSR-GGT axis activity. Int J Med Sci. 2021;18(8):1899–1909.
   PubMed Web of Science ®Google Scholar
• Liu M, Fan Y, Li D, et al. Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Mol Oncol. 2021;15(8):2084–2105.
   PubMed Web of Science ®Google Scholar
• Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica. 1995;80(3):252–267.
   PubMed Web of Science ®Google Scholar
• Masson PL, Heremans JF, Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med. 1969;130(3):643–658.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lu M, Chen C, et al. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer. Theranostics. 2021;11(7):3167–3182.
   PubMed Web of Science ®Google Scholar
• Parikh PM, Vaid A, Advani SH, et al. Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(31):4129–4136.
   PubMed Web of Science ®Google Scholar
• Deng S-H, Wu D-M, Li L, et al. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549. Biochem Biophys Res Commun. 2021;549:54–60.
   PubMed Web of Science ®Google Scholar
• Wei D, Ke Y-Q, and Duan P, et al. MicroRNA-302a-3p induces ferroptosis of non-small cell lung cancer cells via targeting ferroportin. Free Radic Res. 2021;55(7):821–830. doi:https://doi.org/10.1080/10715762.2021.1947503.
   PubMed Web of Science ®Google Scholar
• Song Z, Jia G, Ma P, et al. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis. Life Sci. 2021;276(31):119399.
   PubMedGoogle Scholar
• Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26(11):2329–2343.
   PubMed Web of Science ®Google Scholar
• Wu F, Mo Q, Wan X, et al. NEAT1/hsa-mir-98-5p/MAPK6 axis is involved in non-small-cell lung cancer development. J Cell Biochem. 2019;120(3):2836–2846.
   PubMed Web of Science ®Google Scholar
• Wu H, Liu A. Long non-coding RNA NEAT1 regulates ferroptosis sensitivity in non-small-cell lung cancer. J Int Med Res. 2021;49:0300060521996183.
   PubMed Web of Science ®Google Scholar
• Hsieh C-H, Hsieh H-C, Shih F-S, et al. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Theranostics. 2021;11(14):7072–7091.
   PubMed Web of Science ®Google Scholar
• de Souza MGF, de Jesus Guedes FN, Tebaldi ML, et al. Ferri-Liposomes: preformulation and selective cytotoxicity against a549 lung cancer cells. Pharmaceutics. 2021;13(5):712.
   PubMed Web of Science ®Google Scholar
• Gai C, Liu C, Wu X, et al., MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells. Cell Death Dis. 2020;11(9):751.
   PubMed Web of Science ®Google Scholar
• Nagpal A, Redvers RP, Ling X, et al. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Res BCR. 2019;21(1):94.
   PubMed Web of Science ®Google Scholar
• Tabnak P, HajiEsmailPoor Z, Soraneh S. Ferroptosis in lung cancer: from molecular mechanisms to prognostic and therapeutic opportunities. Front Oncol. 2021;11:792827.
   PubMed Web of Science ®Google Scholar
• Wohlhieter CA, Richards AL, Uddin F, et al. Concurrent Mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer. Cell Rep. 2020;33(9):108444.
   PubMed Web of Science ®Google Scholar
• Lai Y, Zhang Z, Li J, et al. STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma. Biochem Biophys Res Commun. 2019;519(4):659–666.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen Y, Wang X, et al. Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11. Cancer Res. 2021;81(20):5217–5229. canres.567.2021.
   PubMed Web of Science ®Google Scholar
• Tang X, Chen W, Liu H, et al. Research progress on SLC7A11 in the regulation of cystine/cysteine metabolism in tumors. Oncol Lett. 2022;23(2):47.
   PubMed Web of Science ®Google Scholar